The Effects of Nitric Oxide on Cardiopon and Bypass Patients

We could not detect a major side effect mode which could be found across the primary outcome or one of the secondary outcomes. In terms of adverse events we only had one event which was classified as possibly related to nitric oxide or bypass and that was patient who developed intra-proteive hypotension with no other clear cause. To the base of our knowledge the nitric represents by far the largest RCT to date in inflatable heart disease. There's a number of anxillary studies and embedded analysis inside the king transcriptomic and follow-up data which will keep us busy for a number of years to come.